Epigenetic silencing of BEND4 unveils new path for PDAC treatment

A novel discovery in the field of pancreatic cancer treatment has been unveiled, revealing the epigenetic silencing of BEND4 as a potential synthetic lethal marker for enhancing the efficacy of ATM inhibitors in pancreatic cancer treatment.

Medtronic names Yarmela Pavlovic as chief regulatory officer

Listen to the article 2 min This audio is auto-generated. Please let us know if you have feedback. Name: Yarmela Pavlovic New title: Chief regulatory

April 24, 2024

Cybin Announces Grant of Additional U.S. Patent in Support of its CYB003 Breakthrough Therapy Program for Major Depressive Disorder | Psychedelic Invest

Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (“Cybin” or the “Company”), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative next-generation psychedelic-based

April 16, 2024

Use of Video Laryngoscopy Reduced Endotracheal Intubation Attempts

Use of hyperangulated video laryngoscopy reduced the number of attempts needed to achieve endotracheal intubation compared with direct laryngoscopy among adults undergoing elective or emergent

March 19, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.